公开(公告)号：US07889856B2

公开(公告)日：2011-02-15

申请号：US11274939

申请日：2005-11-15

Applicant: Bin Wang ,  Yihua Cheng ,  Xiaoqing Hu ,  Xiaojun Mo ,  Jihong Dong ,  Qian Yu ,  Xuanming Lu ,  Xiaodong Zhao ,  Yongfeng Cai ,  Junrong Xu ,  Guodao Yang ,  Youjun Chen ,  Zujian Li ,  Guofan Tong ,  Shichang Xiao ,  Yi Zhang ,  Jiaqing Liu ,  Yonghong Wu ,  Shiqian Li

Inventor： Bin Wang ,  Yihua Cheng ,  Xiaoqing Hu ,  Xiaojun Mo ,  Jihong Dong ,  Qian Yu ,  Xuanming Lu ,  Xiaodong Zhao ,  Yongfeng Cai ,  Junrong Xu ,  Guodao Yang ,  Youjun Chen ,  Zujian Li ,  Guofan Tong ,  Shichang Xiao ,  Yi Zhang ,  Jiaqing Liu ,  Yonghong Wu ,  Shiqian Li

IPC: H04M5/00

CPC classification number: H04M3/42068 ,  H04M3/42017 ,  H04M3/4211 ,  H04M3/487 ,  H04M2203/2072

Abstract: Disclosed are systems and methods for providing ring back tones in a communication network. At first, a ring back tone device for storing and playing the ring back tone customized by a subscriber is established in the communication network. Whether a subscriber is a ring back tone service register subscriber is judged with a certain triggering mode, such as intelligent network triggering, signaling interception triggering, call forwarding triggering or switching device triggering. If it is judged the subscriber is a ring back tone service registered subscriber, a connection between the originating switching device and the terminating switching device and a connection between a switching device and the ring back tone device are established. When the called terminal is idle, the ring back tone device provides a piece of customized ring back tone to the calling subscriber for replacing traditional ring back tone.

Abstract translation: 公开了用于在通信网络中提供回铃音的系统和方法。 首先，在通信网络中建立用于存储和播放由订户定制的回铃音的回铃音设备。 通过智能网络触发，信令拦截触发，呼叫转移触发或切换设备触发等某种触发模式来判断用户是否是回铃音服务注册用户。 如果判断用户是回铃音业务注册用户，则建立起始交换设备与终端交换设备之间的连接以及交换设备与回铃音设备之间的连接。 当被叫终端空闲时，回铃音设备向主叫用户提供一段定制的回铃音，以取代传统的回铃音。

公开(公告)号：US20100210648A1

公开(公告)日：2010-08-19

申请号：US12713777

申请日：2010-02-26

Applicant: Bin Wang ,  Tao Wang

Inventor： Bin Wang ,  Tao Wang

IPC: A61K31/5377 ,  C07D401/14 ,  A61K31/506 ,  A61P35/00 ,  A61P35/02 ,  C07D413/14

CPC classification number: C07D401/14

Abstract: This invention relates to novel compounds having the formula (I): and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.

Abstract translation: 本发明涉及具有式（I）的新化合物及其药物组合物及其使用方法。 这些新型化合物为癌症提供治疗。

公开(公告)号：US20090297476A1

公开(公告)日：2009-12-03

申请号：US12118624

申请日：2008-05-09

Applicant: SCOTT SEIWERT ,  STEVEN W. ANDREWS ,  LEONID BEIGELMAN ,  LAWRENCE M. BLATT ,  BRAD BUCKMAN ,  Kevin R. Condroski ,  Yutong Jiang ,  Robert J. Kaus ,  April L. Kennedy ,  Timonthy S. Kercher ,  Michael A. Lyon ,  Bin Wang

Inventor： SCOTT SEIWERT ,  STEVEN W. ANDREWS ,  LEONID BEIGELMAN ,  LAWRENCE M. BLATT ,  BRAD BUCKMAN ,  Kevin R. Condroski ,  Yutong Jiang ,  Robert J. Kaus ,  April L. Kennedy ,  Timonthy S. Kercher ,  Michael A. Lyon ,  Bin Wang

IPC: A61K38/21 ,  C12N9/99 ,  A61K31/7088 ,  A61K31/5377 ,  A61K31/4439 ,  A61K31/427 ,  C07D413/14 ,  C07D417/14

CPC classification number: C07D217/26 ,  C07D401/12 ,  C07D417/14

Abstract: The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments provide compounds of the general Formula II, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

Abstract translation: 实施方案提供了通式I的化合物，以及包含主题化合物的组合物，包括药物组合物。 实施方案提供了通式II的化合物，以及包含主题化合物的组合物，包括药物组合物。 实施方案还提供治疗方法，包括治疗丙型肝炎病毒感染的方法和治疗肝纤维化的方法，所述方法通常涉及向有需要的个体施用有效量的主题化合物或组合物。

公开(公告)号：US20080155834A1

公开(公告)日：2008-07-03

申请号：US11648515

申请日：2006-12-29

Applicant: Five-Tiger Li ,  Sam Zhang ,  Tiger Lou ,  Bin Wang

Inventor： Five-Tiger Li ,  Sam Zhang ,  Tiger Lou ,  Bin Wang

IPC: B26B19/38

CPC classification number: B26B19/04 ,  B26B19/063 ,  B26B19/3853 ,  B26B19/386

Abstract: A hair trimmer includes a handle having a housing including an actuation assembly rotatable relative to the housing, and a blade assembly including a reciprocating blade, a stationary blade and a blade assembly housing, the blade assembly constructed and arranged for being detachably engaged to the actuation assembly in a plane of rotation of the actuation assembly.

Abstract translation: 一种修剪器包括具有壳体的手柄，该壳体包括可相对于壳体旋转的致动组件，以及包括往复式叶片，固定叶片和叶片组件壳体的叶片组件，所述叶片组件构造和布置成可拆卸地接合到致动器 组件在致动组件的旋转平面中。

公开(公告)号：US07257033B2

公开(公告)日：2007-08-14

申请号：US11084214

申请日：2005-03-17

Applicant: Bin Wang ,  Chih-Hsin Wang ,  William T. Colleran

Inventor： Bin Wang ,  Chih-Hsin Wang ,  William T. Colleran

IPC: G11C16/04

CPC classification number: G11C16/10

Abstract: NVM arrays include rows and columns of NVM cells comprising a floating gate, dual transistor, inverter storage element. Supply voltage for selected storage elements is turned off during a programming and an erase mode. Isolation transistors for each NVM cell or for each row of NVM cells may be used to control the supply voltage.

Abstract translation: NVM阵列包括包括浮动栅极，双晶体管，逆变器存储元件的NVM单元的行和列。 在编程和擦除模式期间，所选存储元件的电源电压关闭。 可以使用每个NVM单元或每行NVM单元的隔离晶体管来控制电源电压。

公开(公告)号：US20070184037A1

公开(公告)日：2007-08-09

申请号：US10590040

申请日：2005-01-31

Applicant: Bin Wang ,  Qingling Yu ,  Huali Jin ,  Youmin Kang

Inventor： Bin Wang ,  Qingling Yu ,  Huali Jin ,  Youmin Kang

IPC: A61K48/00 ,  C12N5/08 ,  C12N5/10

CPC classification number: A61K39/00 ,  A61K48/00 ,  A61K2039/57

Abstract: The present invention discloses a T-cell immune response inhibitor. The T-cell immune response inhibitor supplied in the present invention comprises a targeted pathogen nucleic acid vaccine and said nucleic acid vaccine's expression protein antigen; or it comprises a targeted pathogen nucleic acid vaccine and said nucleic acid vaccine expression protein antigen's active polypeptide; or it comprises the inactivated pathogen and targeted pathogen nucleic acid vaccine. The T-cell immune response inhibitor in the present invention is able to stimulate the organism to produce the normal specific antibody immune response and to suppress a specific cell's immune response, in particular the Th1 immune response, thus it may be effectively applied to treatment of autoimmune diseases, organ transplants, allergies and control of T-cell levels.

Abstract translation: 本发明公开了一种T细胞免疫应答抑制剂。 本发明提供的T细胞免疫应答抑制剂包含靶向病原体核酸疫苗和所述核酸疫苗的表达蛋白质抗原; 或者其包含靶向病原体核酸疫苗和所述核酸疫苗表达蛋白抗原的活性多肽; 或者其包含灭活的病原体和靶向的病原体核酸疫苗。 本发明中的T细胞免疫应答抑制剂能够刺激生物体产生正常的特异性抗体免疫应答并抑制特定细胞的免疫应答，特别是Th1免疫应答，因此可有效地应用于治疗 自身免疫疾病，器官移植，过敏和T细胞水平的控制。

公开(公告)号：US20070142413A1

公开(公告)日：2007-06-21

申请号：US10595807

申请日：2004-11-15

Applicant: Michael Block ,  John Lee ,  David Scott ,  Haixia Wang ,  Tao Wang ,  Dingwei Yu ,  Yongxin Han ,  John Josey ,  Bin Wang

Inventor： Michael Block ,  John Lee ,  David Scott ,  Haixia Wang ,  Tao Wang ,  Dingwei Yu ,  Yongxin Han ,  John Josey ,  Bin Wang

IPC: A61K31/506 ,  C07D403/14 ,  C07D413/14

CPC classification number: C07D401/14 ,  C07D403/12 ,  C07D403/14 ,  C07D409/14 ,  C07D413/14 ,  C07D417/04 ,  C07D471/04 ,  C07D487/04 ,  C07D495/04

Abstract: Compounds of formula (I): and their use in the inhibition of Trk activity are described.

Abstract translation: 描述式（I）化合物及其在抑制Trk活性中的用途。

公开(公告)号：USD530306S1

公开(公告)日：2006-10-17

申请号：US29227677

申请日：2005-04-13

Applicant: Bin Wang ,  Haibing Li

Designer： Bin Wang ,  Haibing Li

公开(公告)号：US20060209597A1

公开(公告)日：2006-09-21

申请号：US11084213

申请日：2005-03-17

Applicant: Bin Wang ,  Christopher Diorio ,  Todd Humes

Inventor： Bin Wang ,  Christopher Diorio ,  Todd Humes

IPC: G11C11/34

CPC classification number: G11C16/24

Abstract: NVM arrays include rows and columns of NVM cells comprising a floating gate, a programming element, and a logic storage element. During a programming or erase mode, the floating gate of each cell is charged to a predetermined level. At the beginning of a read mode, all storage elements are pre-charged to a high supply voltage level. Following the pre-charge, selected cells are read to determine stored bit values. A charge status of the floating gate of each cell determines whether the storage element is turned on and the pre-charge voltage is pulled down corresponding to a bit value.

Abstract translation: NVM阵列包括包括浮动栅极，编程元件和逻辑存储元件的NVM单元的行和列。 在编程或擦除模式期间，每个单元的浮置栅极被充电到预定的电平。 在读取模式开始时，所有存储元件都被预先充电到高电源电压。 在预充电之后，读取所选择的单元以确定存储的位值。 每个单元的浮动栅极的充电状态确定存储元件是否导通，并且预充电电压相应于位值被下拉。

公开(公告)号：US07001759B1

公开(公告)日：2006-02-21

申请号：US09359975

申请日：1999-07-23

Applicant: David B. Weiner ,  William V. Williams ,  Bin Wang

Inventor： David B. Weiner ,  William V. Williams ,  Bin Wang

IPC: A61K31/167 ,  C12N15/63 ,  C12N15/87 ,  C07H21/04

CPC classification number: A61K39/21 ,  A61K39/00 ,  A61K39/0011 ,  A61K39/0225 ,  A61K39/12 ,  A61K39/29 ,  A61K39/292 ,  A61K2039/53 ,  A61K2039/55516 ,  C12N15/63 ,  C12N2730/10134 ,  C12N2740/16034 ,  C12N2740/16134 ,  C12N2740/16234 ,  C12N2760/20134 ,  C12N2770/24234 ,  Y02A50/464 ,  Y02A90/26 ,  Y10S514/818

Abstract: Methods of introducing genetic material into cells of an individual and compositions and kits for practicing the same are disclosed. The methods comprise the steps of contacting cells of an individual with a polynucleotide function enhancer and administering to the cells, a nucleic acid molecule that is free of retroviral particles. The nucleic acid molecule comprises a nucleotide sequence that encodes a protein that comprises at least one epitope that is identical or substantially similar to an epitope of a pathogen antigen or an antigen associated with a hyperproliferative or autoimmune disease, a protein otherwise missing from the individual due to a missing, non-functional, or partially functioning gene, or a protein that produces a therapeutic effect on an individual. Methods of prophylactically and therapeutically immunizing an individual against pathogens are disclosed. Pharmaceutical compositions and kits for practicing methods of the present invention are disclosed.

Abstract translation: 公开了将遗传物质引入个体细胞的方法和用于实施其的组合物和试剂盒。 所述方法包括使个体的细胞与多核苷酸功能增强子接触并向细胞施用不含逆转录病毒颗粒的核酸分子的步骤。 核酸分子包含编码蛋白质的核苷酸序列，该蛋白质包含与病原体抗原或与过度增殖或自身免疫疾病相关的抗原的表位相同或基本相似的至少一个表位， 涉及一种缺失的，非功能的或部分功能的基因或对个体产生治疗作用的蛋白质。 公开了预防和治疗个体免受病原体的方法。 公开了用于本发明的实践方法的药物组合物和试剂盒。